Nasal Deposition and Clearance in Man: Comparison of a Bidirectional Powder Device and a Traditional Liquid Spray Pump
Open accessAbstract
Background: Delivery of powder formulations to the nose is an attractive alternative for many drugs and vaccines. This study compared the regional nasal deposition and clearance patterns of lactose powder delivered by the OptiNose powder device (Opt-Powder; OptiNose US Inc., Yardley, PA, USA) to that of liquid aerosol administered via a traditional hand-actuated liquid spray pump (Rexam SP270, Rexam Pharma, France). Methods: The study was an open-label, crossover design in seven healthy subjects (five females, two males). The regional nasal deposition and clearance patterns of the Opt-Powder device were compared to a traditional liquid spray pump by dynamic gamma camera imaging after administration of either 99m Tc-labeled lactose powder or liquid 99m Tc- diethelyne triamine pentaacetic acid-aerosol. The gamma camera images were scaled and aligned with sagittal magnetic resonance images to identify nasal regions. Possible deposition of radiolabeled material in the lungs following both methods of delivery was also evaluated. Results: Both powder and spray were distributed to all of the nasal regions. The Opt-Powder device, however, achieved significantly larger initial deposition in the upper and middle posterior regions of the nose than spray (upper posterior region; Opt-Powder 18.3%±11.5 vs. Spray 2.4%±1.8, p <0.02; sum of upper and middle posterior regions; Opt-Powder 53.5%±18.5 vs. Spray 15.7%±13.8, p <0.02). The summed initial deposition to the lower anterior and posterior regions for spray was three times higher compared to Opt-Powder (Opt-Powder 17.4%±24.5 vs. Spray 59.4%±18.2, p <0.04). OptiNose powder delivery resulted in more rapid overall nasal clearance. No lung deposition was observed. Conclusions: The initial deposition following powder delivery was significantly larger in the ciliated mucosa of the upper and posterior nasal regions, whereas less was deposited in the lower regions. Overall nasal clearance of powder was slower initially, but due to retention in anterior nonciliated regions the overall nasal clearance after spray was slower.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The Breath Powered device was shown to enhance deposition in intranasal sites targeted for nose-to-brain transport.
“using a novel Breath Powered device shown to enhance deposition in intranasal sites targeted for nose-to-brain transport.38, 39”
The citation lists haven’t been fetched yet
References 28 · Cited by 170
- Authors
- Djupesland, P. G., & Skretting, A.
- Affiliations
- Centre de Sociologie des Organisations (FR)
- Oslo University Hospital (NO)
- Corresponding author
- Djupesland, Per Gisle
- Venue
- Journal of Aerosol Medicine and Pulmonary Drug Delivery
- Publisher
- SAGE Publications
- Published
- 2012-01-17
- Volume
- 25
- Issue
- 5
- Pages
- 280-289
- ISSN
- 1941-2703 (ISSN-L)
- 1941-2711
- OpenAlex
- W1994848292
- Cited by
- 170
- References
- 28
- Citations by year
- 2026: 13 · 2025: 17 · 2024: 13 · 2023: 12 · 2022: 14 · 2021: 22 · 2020: 15 · 2019: 13 · 2018: 13 · 2017: 4 · 2016: 10 · 2015: 7 · 2014: 6 · 2013: 6 · 2012: 5
- FWCI
- 6.18
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Aerosol Medicine and Pulmonary Drug Delivery (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- International Headache Society
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Inhalation and Respiratory Drug Delivery
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Health Sciences › Medicine › Surgery › Nasal Surgery and Airway Studies
- Keywords
- intranasal drug delivery, nasal clearance, lactose powder, gamma camera imaging, lung deposition, nasal anatomy
- MeSH terms
- Administration, Intranasal, Adult, Aerosols, Equipment Design, Female, Humans, Lactose, Lung, Magnetic Resonance Imaging, Male, Nasal Cavity, Nasal Mucosa, Powders, Technetium, Technetium Tc 99m Pentetate, Drug Delivery Systems, Cross-Over Studies, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review